Homeobox protein Hox-B7 messenger RNA (HOXB7 mRNA)

Homeobox protein Hox-B7 (HOXB7) mRNA is the transcript of the HOXB7 gene, which encodes a sequence-specific transcription factor belonging to the Antp homeobox family [UniProt, GeneCards]. In normal physiology, HOXB7 is essential for embryonic development, where it regulates cell differentiation and provides positional identity along the anterior-posterior axis [UniProt, Wikipedia]. However, HOXB7 mRNA is frequently overexpressed in various malignancies, including breast, pancreatic, and lung cancers, where it functions as an oncogene by promoting cell proliferation, angiogenesis, and the epithelial-mesenchymal transition (EMT) [NIH, unimore.it]. It is also a critical mediator of resistance to endocrine therapies like tamoxifen, as it can act as a co-activator for the estrogen receptor and stimulate the EGFR/HER2 signaling pathways [NIH, ResearchGate]. Because of its central role in tumor progression and drug resistance, HOXB7 mRNA is a significant therapeutic target; experimental strategies such as small interfering RNAs (siRNAs) and antisense oligonucleotides (ASOs) have been shown to effectively silence its expression, leading to increased apoptosis and reduced metastatic potential in preclinical models [NIH, ResearchGate]. Additionally, small molecules like NU-1025 and vinburnine have been identified as potential inhibitors through connectivity map analysis [NIH]. Monitoring HOXB7 mRNA levels may also serve as a valuable prognostic biomarker for predicting patient outcomes and treatment response [NIH].

Other names

HOX2HOX2CHHO.C1Homeobox protein Hox-B7Homeobox protein Hox-2CHox-2.3Homeo box B7

RNA interference (RNAi) or antisense-mediated degradation of the target mRNA, leading to the knockdown of HOXB7 protein expression and subsequent inhibition of oncogenic signaling pathways such as AKT, MAPK/ERK, and TGF-beta.